The Cigna Specialty Care Options^® and Cigna Specialty Care Options Plus^® programs identify customers whose nononcology and oncology specialty medications are being administered in a higher-intensity setting (e.g., outpatient hospital) to determine whether a less-intensive site of care is clinically appropriate. These customers are identified at the time of prior authorization.

Cigna Healthcare recently expanded the Specialty Care Options and Specialty Care Options Plus drug list to include the specialty medical injectables listed below.

Specialty Care Options Program

¹Effective January 1, 2027 for Individual & Family Plans.

Specialty Care Options Plus program

¹Effective January 1, 2027 for Individual & Family Plans.

Additional information

To access the Specialty Care Options and Specialty Care Options Plus drug list, log in to the Cigna for Health Care Professionals website (CignaforHCP.com) and go to Resources > Reimbursement and Payment Policies > Precertification Policies > Specialty Care Options and Specialty Care Options Plus list. We recommend you review this list frequently, as it is subject to change. New-to-market specialty medical injectables may be added upon U.S. Food and Drug Administration approval.

The Specialty Care Options and Specialty Care Options Plus programs contain a medical necessity site-of-care review in accordance with our Medication Administration Site of Care coverage policy.